|
Volumn 17, Issue 7, 2000, Pages 543-545
|
Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1α gene mutations: Evidence for pharmacogenetics in diabetes
|
Author keywords
Genetics; HNF 1 ; MODY; Pharmacogenetics; Sulphonylurea sensitivity
|
Indexed keywords
CHLORPROPAMIDE;
FRUCTOSAMINE;
GLIBENCLAMIDE;
GLUCOSE;
HEMOGLOBIN A1C;
METFORMIN;
NUCLEAR FACTOR I;
SULFONYLUREA DERIVATIVE;
TOLBUTAMIDE;
ADULT;
ARTICLE;
CASE REPORT;
DRUG SENSITIVITY;
FEMALE;
GENE;
GENE MUTATION;
HUMAN;
HYPOGLYCEMIA;
MALE;
MATURITY ONSET DIABETES MELLITUS;
PHARMACOGENETICS;
ADULT;
AMINO ACID SUBSTITUTION;
CHLORPROPAMIDE;
DIABETES MELLITUS, TYPE 2;
DNA TRANSPOSABLE ELEMENTS;
DNA-BINDING PROTEINS;
FEMALE;
GLYBURIDE;
HEPATOCYTE NUCLEAR FACTOR 1;
HEPATOCYTE NUCLEAR FACTOR 1-ALPHA;
HEPATOCYTE NUCLEAR FACTOR 1-BETA;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
METFORMIN;
MIDDLE AGED;
NUCLEAR PROTEINS;
POINT MUTATION;
SULFONYLUREA COMPOUNDS;
TRANSCRIPTION FACTORS;
|
EID: 0033847575
PISSN: 07423071
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1464-5491.2000.00305.x Document Type: Article |
Times cited : (246)
|
References (9)
|